Scientists have developed a cutting-edge way to fight stubborn UTIs by using nanogels to deliver antibiotics directly to ...

Urinary tract infections (UTIs) are the most common infectious ... Antimicrobial resistance is compromising drug therapy. E. coli remains the predominant uropathogen. Newer antimicrobial agents ...

Researchers from the University of Colorado Anschutz Medical Campus studied a new method to deliver antibiotics, specifically ...

Researchers have studied a new method to deliver antibiotics, specifically gentamicin, directly into the bladder tissue to better treat UTIs. They did this by creating nanogels combined with a special ...

The FDA has approved Allecra Therapeutics' Exblifep, a combination antibiotic for complicated urinary tract infections (cUTIs ... for the drug. Cefepime was first introduced in the 1990s, but ...

phenazopyridine — a drug for urinary tract infections (UTIs), or the antibiotic isoniazid. Talk to your doctor if your pee is orange. Pink or red urine Eating foods such as blackberries ...

Zydus Lifesciences has received USFDA approval to manufacture its generic version of Methenamine Hippurate tablets for ...

UTI symptoms can linger after a round of antibiotic treatment. This may happen if you have another type of infection with similar symptoms or need a different kind of treatment. Doctors typically ...

However, ciprofloxacin and levofloxacin are most commonly used to treat UTI because clinicians frequently fear that ... “Unless a patient has a history of drug resistance or intolerance or lives in a ...

The standard treatment for a UTI is antibiotics, which kill the bacteria causing the infection. Doctors will prescribe an antifungal medication instead if a fungus is causing the UTI. It is ...

Some people often use bladder infections and urinary tract infections (UTIs) interchangeably. Both bacterial infections can make you feel like you constantly need to pee, often accompanied by a ...

Zydus Lifesciences receives USFDA approval for Methenamine Hippurate Tablets, strengthening position in US market.